Explaining the Gallium 68 DOTATATE PET with Thomas Hope, MD

Interested in learning more about the Gallium 68 DOTATATE PET? Thomas Hope, MD, a neuroendocrine cancer expert, answers questions about the Gallium 68 DOTATATE PET, including on what occasions should NET patients receive a DOTATATE PET?

This Q&A is an excerpt from the Facebook Live event on September 23, 2018. Watch the full Facebook Live program here:   / 1124105761111555  

Resources mentioned in this video:
NCCN Neuroendocrine Tumor Guidelines for Patients: https://www.nccn.org/patients/guideli...

NCCN Clinical Practice Guidelines for Physicians: https://www.nccn.org/professionals/ph...

Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors: https://nanets.net/images/Guidelines/...

NANETS (North American Neuroendocrine Tumor Society) Guidelines: https://nanets.net/net-guidelines-lib...